KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $40.7 billion.

  • Gilead Sciences' Non-Current Assets rose 229.71% to $40.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $161.0 billion, marking a year-over-year decrease of 489.19%. This contributed to the annual value of $39.8 billion for FY2024, which is 1350.56% down from last year.
  • Per Gilead Sciences' latest filing, its Non-Current Assets stood at $40.7 billion for Q3 2025, which was up 229.71% from $41.0 billion recorded in Q2 2025.
  • Gilead Sciences' Non-Current Assets' 5-year high stood at $54.2 billion during Q1 2021, with a 5-year trough of $39.5 billion in Q1 2025.
  • Moreover, its 5-year median value for Non-Current Assets was $48.1 billion (2023), whereas its average is $46.6 billion.
  • In the last 5 years, Gilead Sciences' Non-Current Assets surged by 7730.7% in 2021 and then plummeted by 1432.76% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Non-Current Assets stood at $53.2 billion in 2021, then dropped by 8.37% to $48.7 billion in 2022, then dropped by 5.52% to $46.0 billion in 2023, then dropped by 13.51% to $39.8 billion in 2024, then increased by 2.1% to $40.7 billion in 2025.
  • Its Non-Current Assets was $40.7 billion in Q3 2025, compared to $41.0 billion in Q2 2025 and $39.5 billion in Q1 2025.